ONO Pharmaceutical USA
Presença
ONO Pharmaceutical é uma das ...
ONO Pharmaceutical é uma empresa listada sob o símbolo 4528 (JP).
ONO Pharmaceutical tem presença direta em 2 países.
Executivos
Veja o organograma con seus 3 executivos principais
Biografias mais buscadas da ONO Pharmaceutical USA
- Kunihiko Ito, President and Chief Executive Officer
- David Trexler, Chief Commercial Officer
- Thomas Lechner, Vice President, Medical Affairs
Criar um alerta
para seguir os movimentos de executivos da ONO Pharmaceutical USA.
Farmacêutica
ONO Pharmaceutical possui 1.860 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de ONO Pharmaceutical USA
- ONO PHARMA USA Announces 2024 Golden Ticket Competition Now Accepting Applications from Innovative Startups | ONO Pharma USA, Inc.
- Newsroom | ONO Pharma USA, Inc.
- ONO PHARMA Announces Enrollment Is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL | ONO Pharma USA, Inc.
- ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University | ONO Pharma USA, Inc.
- Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins | ONO Pharma USA, Inc.
- ONO Selected as Highest Rating A-List Company by CDP in Two Categories of “Climate Change” and “Water Security” in CDP 2023 | ONO Pharma USA, Inc.
- Support for Disasters Caused by the 2024 Noto Peninsula Earthquake | ONO Pharma USA, Inc.
- Ono Enters into Collaboration Agreement with EVQLV to Generate Novel Antibodies against Multiple Targets Utilizing EVQLV’s AI-powered Antibody Design Engine for Development of Innovative Antibody Drugs | ONO Pharma USA, Inc.
- ONO Selected for the DJSI World Index and DJSI Asia Pacific Index for Four Straight Years | ONO Pharma USA, Inc.
- Ono Enters into a Drug Discovery Collaboration Agreement with Adimab to Discover Novel Antibody Drugs in the Oncology Field | ONO CORPORATEicon_search_whiteicon_close_wicon_search_g
- View more press releases Close
Redes sociais sobre ONO Pharmaceutical USA
- ONO Pharmaceutical USA na Wikipedia, Google News e Yahoo Finance
- ONO Pharmaceutical USA na LinkedIn, Twitter e YouTube
